Highlights

[DPHARMA] YoY Cumulative Quarter Result on 2013-09-30 [#3]

Stock [DPHARMA]: DUOPHARMA BIOTECH BHD
Announcement Date 19-Nov-2013
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2013
Quarter 30-Sep-2013  [#3]
Profit Trend QoQ -     39.03%    YoY -     20.77%
Quarter Report


View:


Show?  YoY % Horiz. %

Cumulative Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 238,907 181,279 125,937 116,671 99,932 105,096 99,242 15.75%
  YoY % 31.79% 43.94% 7.94% 16.75% -4.91% 5.90% -
  Horiz. % 240.73% 182.66% 126.90% 117.56% 100.70% 105.90% 100.00%
PBT 25,180 32,226 32,589 31,017 26,298 26,892 26,802 -1.03%
  YoY % -21.86% -1.11% 5.07% 17.94% -2.21% 0.34% -
  Horiz. % 93.95% 120.24% 121.59% 115.73% 98.12% 100.34% 100.00%
Tax -7,185 -8,786 -8,014 -6,842 -6,281 -6,515 -6,747 1.05%
  YoY % 18.22% -9.63% -17.13% -8.93% 3.59% 3.44% -
  Horiz. % 106.49% 130.22% 118.78% 101.41% 93.09% 96.56% 100.00%
NP 17,995 23,440 24,575 24,175 20,017 20,377 20,055 -1.79%
  YoY % -23.23% -4.62% 1.65% 20.77% -1.77% 1.61% -
  Horiz. % 89.73% 116.88% 122.54% 120.54% 99.81% 101.61% 100.00%
NP to SH 18,867 23,440 24,575 24,175 20,017 20,377 20,055 -1.01%
  YoY % -19.51% -4.62% 1.65% 20.77% -1.77% 1.61% -
  Horiz. % 94.08% 116.88% 122.54% 120.54% 99.81% 101.61% 100.00%
Tax Rate 28.53 % 27.26 % 24.59 % 22.06 % 23.88 % 24.23 % 25.17 % 2.11%
  YoY % 4.66% 10.86% 11.47% -7.62% -1.44% -3.73% -
  Horiz. % 113.35% 108.30% 97.70% 87.64% 94.87% 96.27% 100.00%
Total Cost 220,912 157,839 101,362 92,496 79,915 84,719 79,187 18.63%
  YoY % 39.96% 55.72% 9.59% 15.74% -5.67% 6.99% -
  Horiz. % 278.98% 199.32% 128.00% 116.81% 100.92% 106.99% 100.00%
Net Worth 451,913 268,509 187,436 179,125 167,965 162,405 148,504 20.36%
  YoY % 68.30% 43.25% 4.64% 6.64% 3.42% 9.36% -
  Horiz. % 304.31% 180.81% 126.22% 120.62% 113.10% 109.36% 100.00%
Dividend
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Div - - 5,553 - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 100.00% - - - -
Div Payout % - % - % 22.60 % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 100.00% - - - -
Equity
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Net Worth 451,913 268,509 187,436 179,125 167,965 162,405 148,504 20.36%
  YoY % 68.30% 43.25% 4.64% 6.64% 3.42% 9.36% -
  Horiz. % 304.31% 180.81% 126.22% 120.62% 113.10% 109.36% 100.00%
NOSH 278,959 166,776 138,841 138,856 138,814 138,807 138,788 12.33%
  YoY % 67.27% 20.12% -0.01% 0.03% 0.00% 0.01% -
  Horiz. % 201.00% 120.17% 100.04% 100.05% 100.02% 100.01% 100.00%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 7.53 % 12.93 % 19.51 % 20.72 % 20.03 % 19.39 % 20.21 % -15.16%
  YoY % -41.76% -33.73% -5.84% 3.44% 3.30% -4.06% -
  Horiz. % 37.26% 63.98% 96.54% 102.52% 99.11% 95.94% 100.00%
ROE 4.17 % 8.73 % 13.11 % 13.50 % 11.92 % 12.55 % 13.50 % -17.77%
  YoY % -52.23% -33.41% -2.89% 13.26% -5.02% -7.04% -
  Horiz. % 30.89% 64.67% 97.11% 100.00% 88.30% 92.96% 100.00%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 85.64 108.70 90.71 84.02 71.99 75.71 71.51 3.05%
  YoY % -21.21% 19.83% 7.96% 16.71% -4.91% 5.87% -
  Horiz. % 119.76% 152.01% 126.85% 117.49% 100.67% 105.87% 100.00%
EPS 6.45 14.04 17.70 17.41 14.42 14.68 14.45 -12.57%
  YoY % -54.06% -20.68% 1.67% 20.74% -1.77% 1.59% -
  Horiz. % 44.64% 97.16% 122.49% 120.48% 99.79% 101.59% 100.00%
DPS 0.00 0.00 4.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 100.00% - - - -
NAPS 1.6200 1.6100 1.3500 1.2900 1.2100 1.1700 1.0700 7.15%
  YoY % 0.62% 19.26% 4.65% 6.61% 3.42% 9.35% -
  Horiz. % 151.40% 150.47% 126.17% 120.56% 113.08% 109.35% 100.00%
Adjusted Per Share Value based on latest NOSH - 941,773
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 25.37 19.25 13.37 12.39 10.61 11.16 10.54 15.75%
  YoY % 31.79% 43.98% 7.91% 16.78% -4.93% 5.88% -
  Horiz. % 240.70% 182.64% 126.85% 117.55% 100.66% 105.88% 100.00%
EPS 2.00 2.49 2.61 2.57 2.13 2.16 2.13 -1.04%
  YoY % -19.68% -4.60% 1.56% 20.66% -1.39% 1.41% -
  Horiz. % 93.90% 116.90% 122.54% 120.66% 100.00% 101.41% 100.00%
DPS 0.00 0.00 0.59 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 100.00% - - - -
NAPS 0.4799 0.2851 0.1990 0.1902 0.1783 0.1724 0.1577 20.36%
  YoY % 68.33% 43.27% 4.63% 6.67% 3.42% 9.32% -
  Horiz. % 304.31% 180.79% 126.19% 120.61% 113.06% 109.32% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 -
Price 2.0600 2.7200 3.1700 2.5500 2.3600 2.1000 2.4400 -
P/RPS 2.41 2.50 3.49 3.03 3.28 2.77 3.41 -5.62%
  YoY % -3.60% -28.37% 15.18% -7.62% 18.41% -18.77% -
  Horiz. % 70.67% 73.31% 102.35% 88.86% 96.19% 81.23% 100.00%
P/EPS 30.46 19.35 17.91 14.65 16.37 14.31 16.89 10.32%
  YoY % 57.42% 8.04% 22.25% -10.51% 14.40% -15.28% -
  Horiz. % 180.34% 114.56% 106.04% 86.74% 96.92% 84.72% 100.00%
EY 3.28 5.17 5.58 6.83 6.11 6.99 5.92 -9.36%
  YoY % -36.56% -7.35% -18.30% 11.78% -12.59% 18.07% -
  Horiz. % 55.41% 87.33% 94.26% 115.37% 103.21% 118.07% 100.00%
DY 0.00 0.00 1.26 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 100.00% - - - -
P/NAPS 1.27 1.69 2.35 1.98 1.95 1.79 2.28 -9.28%
  YoY % -24.85% -28.09% 18.69% 1.54% 8.94% -21.49% -
  Horiz. % 55.70% 74.12% 103.07% 86.84% 85.53% 78.51% 100.00%
Price Multiplier on Announcement Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 21/11/16 24/11/15 21/11/14 19/11/13 23/11/12 21/11/11 26/11/10 -
Price 2.1000 2.7000 3.0100 2.5600 2.2800 2.1000 2.3800 -
P/RPS 2.45 2.48 3.32 3.05 3.17 2.77 3.33 -4.98%
  YoY % -1.21% -25.30% 8.85% -3.79% 14.44% -16.82% -
  Horiz. % 73.57% 74.47% 99.70% 91.59% 95.20% 83.18% 100.00%
P/EPS 31.05 19.21 17.01 14.70 15.81 14.31 16.47 11.14%
  YoY % 61.63% 12.93% 15.71% -7.02% 10.48% -13.11% -
  Horiz. % 188.52% 116.64% 103.28% 89.25% 95.99% 86.89% 100.00%
EY 3.22 5.21 5.88 6.80 6.32 6.99 6.07 -10.02%
  YoY % -38.20% -11.39% -13.53% 7.59% -9.59% 15.16% -
  Horiz. % 53.05% 85.83% 96.87% 112.03% 104.12% 115.16% 100.00%
DY 0.00 0.00 1.33 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 100.00% - - - -
P/NAPS 1.30 1.68 2.23 1.98 1.88 1.79 2.22 -8.53%
  YoY % -22.62% -24.66% 12.63% 5.32% 5.03% -19.37% -
  Horiz. % 58.56% 75.68% 100.45% 89.19% 84.68% 80.63% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


TOP ARTICLES

1. Why is Mr Ooi Teck Bee’s Rm 1.16 target for Hiap Teck easily achievable? Koon Yew Yin Koon Yew Yin's Blog
2. Opportunities abound for Hong Kong construction sector Good Articles to Share
3. Reposted article: THE IMPORTANCE OF DIVERSIFICATION (Calvin Tan) This is a 3rd posting to warn about Black Swan event THE INVESTMENT APPROACH OF CALVIN TAN
4. PublicInvest Research Headlines - 25 Oct 2021 PublicInvest Research
5. Moscow decries U.S. move to call Russians 'homeless' for visa purposes Good Articles to Share
6. NOW SHOWING : THE TRILOGY OF FAST & FURIOUS SHOW - PART 13 SUPER BULL STOCKS -Super Positive Momentum Stocks - FOR SEE_Research
7. As outbreak worsens, Covid-19 cases in eastern Europe near 20 million Good Articles to Share
8. Biden sparks confusion with commitment to Taiwan’s defence if Beijing attacks Good Articles to Share
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

415  465  583  824 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 DNEX 0.77+0.015 
 MINETEC-PA 0.035+0.035 
 AT 0.055-0.005 
 FITTERS 0.435+0.02 
 MTRONIC 0.025-0.005 
 MYEG 1.09+0.05 
 LKL 0.125-0.01 
 NWP 0.275-0.015 
 KANGER 0.050.00 
 OPCOM 1.29-0.04 
PARTNERS & BROKERS